Attached files
file | filename |
---|---|
10-Q - INTEGRATED BIOPHARMA INC | inb10q_20100211.htm |
EX-10 - INTEGRATED BIOPHARMA INC | exhibit10_1.htm |
EX-32 - INTEGRATED BIOPHARMA INC | exhibit32_2.htm |
EX-31 - INTEGRATED BIOPHARMA INC | exhibit31_1.htm |
EX-31 - INTEGRATED BIOPHARMA INC | exhibit31_2.htm |
Exhibit
32.1
CERTIFICATION OF PERIODIC
REPORT
As
adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In
connection with the Quarterly Report on Form 10-Q for the second quarter ended
December 31, 2009 of Integrated BioPharma, Inc. (the “Company”) as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), E.
Gerald Kay, the President and Chief Executive Officer of Integrated BioPharma,
Inc. certifies,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350, that to his knowledge:
(1)
|
the
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
and
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
This
certification accompanies the Report pursuant to Section 906 of Sarbanes-Oxley
Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley
Act of 2002, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended.
A signed
original of this written statement has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.
Dated: February
12, 2010
By: /s/ E. Gerald
Kay
E. Gerald Kay
President and Chief Executive
Officer